$CYTH
Cyclo Therapeutics, Inc.

2018 Q1 Form 10-Q Financial Statement

#000143774918009988 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q1
Revenue $198.1K $170.0K $305.1K
YoY Change -35.07% -67.92% -1.59%
Cost Of Revenue $23.67K $20.00K $19.38K
YoY Change 22.16% -75.0% -51.56%
Gross Profit $174.4K $150.0K $285.7K
YoY Change -38.95% -66.67% 5.81%
Gross Profit Margin 88.05% 88.24% 93.65%
Selling, General & Admin $580.0K $740.0K $640.0K
YoY Change -9.38% 23.33% 0.0%
% of Gross Profit 332.57% 493.33% 224.03%
Research & Development $409.2K $780.0K $643.6K
YoY Change -36.42% 27.87% 129.87%
% of Gross Profit 234.64% 520.0% 225.3%
Depreciation & Amortization $2.500K $0.00 $2.208K
YoY Change 13.22% -100.0% -94.48%
% of Gross Profit 1.43% 0.0% 0.77%
Operating Expenses $409.2K $1.530M $643.6K
YoY Change -36.42% 24.39% -33.64%
Operating Profit -$814.4K -$1.380M -$990.5K
YoY Change -17.78% 76.92% 41.5%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $1.432K $3.018K
YoY Change -52.55%
Pretax Income -$812.9K -$1.380M -$987.5K
YoY Change -17.67% 66.27% 39.08%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$812.9K -$1.380M -$987.5K
YoY Change -17.67% 66.27% 39.08%
Net Earnings / Revenue -410.43% -811.76% -323.7%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.110M -$1.890M -$1.435M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $610.0K $1.270M $1.640M
YoY Change -62.8% 32.29% 51.85%
Cash & Equivalents $609.6K $1.271M $1.638M
Short-Term Investments
Other Short-Term Assets $65.10K $60.85K $60.00K
YoY Change 8.51% 12.93% 50.0%
Inventory $453.4K $471.2K $500.0K
Prepaid Expenses
Receivables $47.68K $56.86K $220.0K
Other Receivables $30.00K $30.00K $40.00K
Total Short-Term Assets $1.212M $1.896M $2.460M
YoY Change -50.75% 15.91% 31.55%
LONG-TERM ASSETS
Property, Plant & Equipment $24.87K $25.74K $30.00K
YoY Change -17.1% -14.17% -98.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $189.1K $192.9K $220.0K
YoY Change -14.06% -17.23% -89.81%
TOTAL ASSETS
Total Short-Term Assets $1.212M $1.896M $2.460M
Total Long-Term Assets $189.1K $192.9K $220.0K
Total Assets $1.401M $2.089M $2.680M
YoY Change -47.73% 11.78% -33.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $990.0K $940.0K $220.0K
YoY Change 350.0% 176.47% -21.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.068M $943.0K $220.0K
YoY Change 385.48% 175.3% -77.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.068M $943.0K $220.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.070M $940.0K $220.0K
YoY Change 386.36% 176.47% -77.78%
SHAREHOLDERS EQUITY
Retained Earnings -$14.15M -$13.33M
YoY Change 40.35%
Common Stock $7.299K $7.299K
YoY Change 9.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $332.7K $1.146M $2.460M
YoY Change
Total Liabilities & Shareholders Equity $1.401M $2.089M $2.680M
YoY Change -47.73% 11.78% -33.5%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q1
OPERATING ACTIVITIES
Net Income -$812.9K -$1.380M -$987.5K
YoY Change -17.67% 66.27% 39.08%
Depreciation, Depletion And Amortization $2.500K $0.00 $2.208K
YoY Change 13.22% -100.0% -94.48%
Cash From Operating Activities -$737.7K -$980.0K -$1.185M
YoY Change -37.73% 75.0% 64.54%
INVESTING ACTIVITIES
Capital Expenditures $1.634K $0.00 $1.605K
YoY Change 1.81% -116.05%
Acquisitions
YoY Change
Other Investing Activities $0.00 $10.00K $10.00K
YoY Change -100.0% -98.92% 0.0%
Cash From Investing Activities $1.300K $10.00K $11.51K
YoY Change -88.71% -98.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.98K 900.0K 1.851M
YoY Change -95.95% -234.33% -3802.11%
NET CHANGE
Cash From Operating Activities -737.7K -980.0K -1.185M
Cash From Investing Activities 1.300K 10.00K 11.51K
Cash From Financing Activities 74.98K 900.0K 1.851M
Net Change In Cash -661.4K -70.00K 677.9K
YoY Change -197.57% -77.42% -188.04%
FREE CASH FLOW
Cash From Operating Activities -$737.7K -$980.0K -$1.185M
Capital Expenditures $1.634K $0.00 $1.605K
Free Cash Flow -$739.3K -$980.0K -$1.186M
YoY Change -37.68% 75.0% 67.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 ctdh Freight And Shipping
FreightAndShipping
1882
CY2017Q1 ctdh Freight And Shipping
FreightAndShipping
1461
CY2016Q1 ctdh Mortgage Loans On Real Estate Monthly Payment
MortgageLoansOnRealEstateMonthlyPayment
3653
CY2017 ctdh Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
3341000
CY2018Q1 ctdh Proceeds From Sale Of Common Stock And Warrants Net Of Issue Costs
ProceedsFromSaleOfCommonStockAndWarrantsNetOfIssueCosts
CY2017Q1 ctdh Proceeds From Sale Of Common Stock And Warrants Net Of Issue Costs
ProceedsFromSaleOfCommonStockAndWarrantsNetOfIssueCosts
1851055
CY2018Q1 ctdh Repairs And Maintenance
RepairsAndMaintenance
CY2017Q1 ctdh Repairs And Maintenance
RepairsAndMaintenance
2792
CY2018Q1 ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
10890
CY2017Q1 ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
10000
CY2017 ctdh Working Capital
WorkingCapital
953000
CY2018Q1 ctdh Working Capital
WorkingCapital
218593
CY2017Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
35884
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
993079
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
943030
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47682
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56860
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1270973
CY2016Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
265000
CY2016Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.0425
CY2018Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
35884
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14470984
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14470984
CY2018Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
75247
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
7299
CY2017Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-197193
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14190
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21500
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28500478
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15085787
CY2018Q1 us-gaap Assets
Assets
1400736
CY2017Q4 us-gaap Assets
Assets
2088648
CY2018Q1 us-gaap Assets Current
AssetsCurrent
1211672
CY2017Q4 us-gaap Assets Current
AssetsCurrent
1895784
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
609559
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
960197
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1638097
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-661414
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
677900
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72991361
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72991361
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72991361
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72991361
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
7299
CY2018Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2500
CY2017Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2208
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23672
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19378
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
1012445
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
1295548
CY2018Q1 us-gaap Depreciation
Depreciation
2500
CY2017Q1 us-gaap Depreciation
Depreciation
2208
CY2018Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
CY2017Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1261
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-812944
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-987473
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017Q4 us-gaap Inventory Net
InventoryNet
471221
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
35859
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-75955
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9178
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
133031
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17778
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2621
CY2018Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4258
CY2017Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
8033
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2018Q1 us-gaap Inventory Net
InventoryNet
453443
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
27500
CY2018Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
27500
CY2018Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1432
CY2017Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3018
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1400736
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2088648
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1068062
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
943030
CY2018Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
164194
CY2017Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
167128
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74983
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1851055
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1300
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1432
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3018
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-814376
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-990491
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11511
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3062000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-737697
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1184666
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-812944
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-987473
CY2018Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
15783
CY2017Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
46807
CY2018Q1 us-gaap Other Assets Current
OtherAssetsCurrent
65104
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
60846
CY2018Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
47867
CY2017Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
132189
CY2018Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-2934
CY2017Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-8466
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1634
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1605
CY2018Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
74983
CY2018Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1985000
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2000000
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2018Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
CY2017Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4650
CY2016Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
10000
CY2018Q1 us-gaap Professional Fees
ProfessionalFees
233976
CY2017Q1 us-gaap Professional Fees
ProfessionalFees
123800
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24870
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25736
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
409198
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
643645
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14145611
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13332667
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
198069
CY2017Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
305057
CY2018Q1 us-gaap Salaries And Wages
SalariesAndWages
277567
CY2017Q1 us-gaap Salaries And Wages
SalariesAndWages
334529
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3300
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11500
CY2018Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
74983
CY2017Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
332674
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1145618
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">(m) USE OF ESTIMATES&#x2013;&#x2013;The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes, including contingencies. Although management bases its estimates on historical experience and assumptions that are believed to be reasonable under the circumstances, actual results could significantly differ from these estimates.</div></div>
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72999361
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69320315

Files In Submission

Name View Source Status
0001437749-18-009988-index-headers.html Edgar Link pending
0001437749-18-009988-index.html Edgar Link pending
0001437749-18-009988.txt Edgar Link pending
0001437749-18-009988-xbrl.zip Edgar Link pending
ctdh-20180331.xml Edgar Link completed
ctdh-20180331.xsd Edgar Link pending
ctdh-20180331_cal.xml Edgar Link unprocessable
ctdh-20180331_def.xml Edgar Link unprocessable
ctdh-20180331_lab.xml Edgar Link unprocessable
ctdh-20180331_pre.xml Edgar Link unprocessable
ctdh20180331_10q.htm Edgar Link pending
ex_114345.htm Edgar Link pending
ex_114346.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending